Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications
Frontiers of Medicine · 2024
DOI: 10.1007/s11684-024-1094-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers of Medicine, 2024. Verfasst von Xiaoye Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China. Hauptthemen laut MEDLINE: Neoplasms, Obesity. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 245 Literaturangaben.
Abstract (Originalsprache)
Existing epidemiologic and clinical studies have demonstrated that obesity is associated with the risk of a variety of cancers. In recent years, an increasing number of experimental and clinical studies have unraveled the complex relationship between obesity and cancer risk and the underlying mechanisms. Obesity-induced abnormalities in immunity and biochemical metabolism, including chronic inflammation, hormonal disorders, dysregulation of adipokines, and microbial dysbiosis, may be important contributors to cancer development and progression. These contributors play different roles in cancer development and progression at different sites. Lifestyle changes, weight loss medications, and bariatric surgery are key approaches for weight-centered, obesity-related cancer prevention. Treatment of obesity-related inflammation and hormonal or metabolic dysregulation with medications has also shown promise in preventing obesity-related cancers. In this review, we summarize the mechanisms through which obesity affects the risk of cancer at different sites and explore intervention strategies for the prevention of obesity-associated cancers, concluding with unresolved questions and future directions regarding the link between obesity and cancer. The aim is to provide valuable theoretical foundations and insights for the in-depth exploration of the complex relationship between obesity and cancer risk and its clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, China.
- Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, 200433, China.
- Department of Neurology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
- Department of Oncology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.
- Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.
Zitieren
APA
Shi, X., Jiang, A., Qiu, Z., Lin, A., Liu, Z., Zhu, L., Mou, W., Cheng, Q., Zhang, J., Miao, K., & Luo, P. (2024). Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications. Frontiers of Medicine. https://doi.org/10.1007/s11684-024-1094-2
Vancouver
Shi X, Jiang A, Qiu Z, Lin A, Liu Z, Zhu L, et al. Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications. Frontiers of Medicine. 2024. doi:10.1007/s11684-024-1094-2
BibTeX
@article{Shi2024,
author = {Shi, Xiaoye and Jiang, Aimin and Qiu, Zhengang and Lin, Anqi and Liu, Zaoqu and Zhu, Lingxuan and Mou, Weiming and Cheng, Quan and Zhang, Jian and Miao, Kai and Luo, Peng},
title = {Novel perspectives on the link between obesity and cancer risk: from mechanisms to clinical implications},
journal = {Frontiers of Medicine},
year = {2024},
doi = {10.1007/s11684-024-1094-2}
}
EUVIMED